Shopping Cart 0
Cart Subtotal
AED 0

Rare Disease Drug Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 8368

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 9102

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 10460

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 10460

Details

According to 99Strategy, the Global Rare Disease Drug Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Rare Disease Drug market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Novartis AG

Bristol-Myers Squibb Company

Celgene Corporation

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Sanofi S.A.

Alexion Pharmaceuticals, Inc.

Eli Lilly and Company

Novo Nordisk A/S

AstraZeneca

Eisai Co., Ltd.

Daiichi Sankyo Company Limited

Bayer AG

GlaxoSmithKline

Merck & Co., Inc.

Johnson & Johnson

Biogen, Inc.

Shire

Amgen, Inc.

Deciphera

Atara Biotherapeutics

ProQR

Key Product Type

>1

0.65 1

<0.1

Market by Application

Hospital Pharmacies

Speciality Pharmacies

Retail pharmacies

Others

Main Aspects covered in the Report

Overview of the Rare Disease Drug market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Table Of Content

Scope

Table of Content

1 Industrial Chain Overview

1.1 Rare Disease Drug Industry

1.1.1 Overview

1.1.2 Characteristics of Rare Disease Drug

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 >1

1.3.2 0.65 1

1.3.3 <0.1

1.4 End-Use List

1.4.1 Demand in Hospital Pharmacies

1.4.2 Demand in Speciality Pharmacies

1.4.3 Demand in Retail pharmacies

1.4.4 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Novartis AG Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Bristol-Myers Squibb Company Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Celgene Corporation Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 F. Hoffmann-La Roche Ltd. Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Pfizer, Inc. Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Sanofi S.A. Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Alexion Pharmaceuticals, Inc. Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Eli Lilly and Company Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Novo Nordisk A/S Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 AstraZeneca Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Eisai Co., Ltd. Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Daiichi Sankyo Company Limited Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Bayer AG Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 GlaxoSmithKline Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Merck & Co., Inc. Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Johnson & Johnson Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Biogen, Inc. Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Shire Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 Amgen, Inc. Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

3.2.20 Deciphera Overview

3.2.20.1 Product Specifications

3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.20.3 Recent Developments

3.2.20.4 Future Strategic Planning

3.2.21 Atara Biotherapeutics Overview

3.2.21.1 Product Specifications

3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.21.3 Recent Developments

3.2.21.4 Future Strategic Planning

3.2.22 ProQR Overview

3.2.22.1 Product Specifications

3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.22.3 Recent Developments

3.2.22.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in >1

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in 0.65 1

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in <0.1

5.2.3.1 Market Size

5.2.3.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Hospital Pharmacies

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Speciality Pharmacies

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Retail pharmacies

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Others

6.2.4.1 Market Size

6.2.4.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Rare Disease Drug Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in >1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in >1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Novartis AG Overview List

Table Rare Disease Drug Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Rare Disease Drug Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Pfizer, Inc. Overview List

Table Rare Disease Drug Business Operation of Pfizer, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Rare Disease Drug Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Alexion Pharmaceuticals, Inc. Overview List

Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly and Company Overview List

Table Rare Disease Drug Business Operation of Eli Lilly and Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novo Nordisk A/S Overview List

Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Rare Disease Drug Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eisai Co., Ltd. Overview List

Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Daiichi Sankyo Company Limited Overview List

Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Rare Disease Drug Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Rare Disease Drug Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merck & Co., Inc. Overview List

Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Rare Disease Drug Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Biogen, Inc. Overview List

Table Rare Disease Drug Business Operation of Biogen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Shire Overview List

Table Rare Disease Drug Business Operation of Shire (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Amgen, Inc. Overview List

Table Rare Disease Drug Business Operation of Amgen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Deciphera Overview List

Table Rare Disease Drug Business Operation of Deciphera (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Atara Biotherapeutics Overview List

Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ProQR Overview List

Table Rare Disease Drug Business Operation of ProQR (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

According to 99Strategy, the Global Rare Disease Drug Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Rare Disease Drug market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Novartis AG

Bristol-Myers Squibb Company

Celgene Corporation

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Sanofi S.A.

Alexion Pharmaceuticals, Inc.

Eli Lilly and Company

Novo Nordisk A/S

AstraZeneca

Eisai Co., Ltd.

Daiichi Sankyo Company Limited

Bayer AG

GlaxoSmithKline

Merck & Co., Inc.

Johnson & Johnson

Biogen, Inc.

Shire

Amgen, Inc.

Deciphera

Atara Biotherapeutics

ProQR

Key Product Type

>1

0.65 1

<0.1

Market by Application

Hospital Pharmacies

Speciality Pharmacies

Retail pharmacies

Others

Main Aspects covered in the Report

Overview of the Rare Disease Drug market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Scope

Table of Content

1 Industrial Chain Overview

1.1 Rare Disease Drug Industry

1.1.1 Overview

1.1.2 Characteristics of Rare Disease Drug

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 >1

1.3.2 0.65 1

1.3.3 <0.1

1.4 End-Use List

1.4.1 Demand in Hospital Pharmacies

1.4.2 Demand in Speciality Pharmacies

1.4.3 Demand in Retail pharmacies

1.4.4 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Novartis AG Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Bristol-Myers Squibb Company Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Celgene Corporation Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 F. Hoffmann-La Roche Ltd. Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Pfizer, Inc. Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Sanofi S.A. Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Alexion Pharmaceuticals, Inc. Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Eli Lilly and Company Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Novo Nordisk A/S Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 AstraZeneca Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Eisai Co., Ltd. Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Daiichi Sankyo Company Limited Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Bayer AG Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 GlaxoSmithKline Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Merck & Co., Inc. Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Johnson & Johnson Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Biogen, Inc. Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Shire Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 Amgen, Inc. Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

3.2.20 Deciphera Overview

3.2.20.1 Product Specifications

3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.20.3 Recent Developments

3.2.20.4 Future Strategic Planning

3.2.21 Atara Biotherapeutics Overview

3.2.21.1 Product Specifications

3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.21.3 Recent Developments

3.2.21.4 Future Strategic Planning

3.2.22 ProQR Overview

3.2.22.1 Product Specifications

3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.22.3 Recent Developments

3.2.22.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in >1

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in 0.65 1

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in <0.1

5.2.3.1 Market Size

5.2.3.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Hospital Pharmacies

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Speciality Pharmacies

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Retail pharmacies

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Others

6.2.4.1 Market Size

6.2.4.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Rare Disease Drug Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in >1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in >1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Novartis AG Overview List

Table Rare Disease Drug Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Rare Disease Drug Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Pfizer, Inc. Overview List

Table Rare Disease Drug Business Operation of Pfizer, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Rare Disease Drug Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Alexion Pharmaceuticals, Inc. Overview List

Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly and Company Overview List

Table Rare Disease Drug Business Operation of Eli Lilly and Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novo Nordisk A/S Overview List

Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Rare Disease Drug Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eisai Co., Ltd. Overview List

Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Daiichi Sankyo Company Limited Overview List

Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Rare Disease Drug Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Rare Disease Drug Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merck & Co., Inc. Overview List

Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Rare Disease Drug Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Biogen, Inc. Overview List

Table Rare Disease Drug Business Operation of Biogen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Shire Overview List

Table Rare Disease Drug Business Operation of Shire (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Amgen, Inc. Overview List

Table Rare Disease Drug Business Operation of Amgen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Deciphera Overview List

Table Rare Disease Drug Business Operation of Deciphera (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Atara Biotherapeutics Overview List

Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ProQR Overview List

Table Rare Disease Drug Business Operation of ProQR (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS